HRT Financial LLC bought a new position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) in the second quarter, Holdings Channel reports. The institutional investor bought 4,743 shares of the medical instruments supplier’s stock, valued at approximately $207,000.

Several other hedge funds also recently added to or reduced their stakes in the company. Riverhead Capital Management LLC increased its stake in shares of DENTSPLY SIRONA by 17.4% during the first quarter. Riverhead Capital Management LLC now owns 7,661 shares of the medical instruments supplier’s stock worth $385,000 after purchasing an additional 1,136 shares in the last quarter. Northwest Investment Counselors LLC increased its stake in shares of DENTSPLY SIRONA by 21.0% during the second quarter. Northwest Investment Counselors LLC now owns 7,582 shares of the medical instruments supplier’s stock worth $332,000 after purchasing an additional 1,318 shares in the last quarter. CIBC Asset Management Inc boosted its position in DENTSPLY SIRONA by 4.7% during the second quarter. CIBC Asset Management Inc now owns 29,581 shares of the medical instruments supplier’s stock worth $1,295,000 after acquiring an additional 1,330 shares during the last quarter. Comerica Bank boosted its position in DENTSPLY SIRONA by 2.3% during the second quarter. Comerica Bank now owns 61,333 shares of the medical instruments supplier’s stock worth $2,803,000 after acquiring an additional 1,400 shares during the last quarter. Finally, CIBC World Markets Inc. boosted its position in DENTSPLY SIRONA by 16.1% during the second quarter. CIBC World Markets Inc. now owns 10,099 shares of the medical instruments supplier’s stock worth $442,000 after acquiring an additional 1,400 shares during the last quarter. 97.65% of the stock is owned by institutional investors and hedge funds.

Shares of XRAY opened at $38.42 on Monday. DENTSPLY SIRONA Inc has a fifty-two week low of $37.46 and a fifty-two week high of $68.98. The company has a market cap of $8.62 billion, a P/E ratio of 14.44, a price-to-earnings-growth ratio of 2.24 and a beta of 1.20. The company has a current ratio of 1.69, a quick ratio of 1.10 and a debt-to-equity ratio of 0.31.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Tuesday, August 7th. The medical instruments supplier reported $0.60 EPS for the quarter, beating the Zacks’ consensus estimate of $0.59 by $0.01. DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. The company had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the prior year, the firm posted $0.65 EPS. research analysts forecast that DENTSPLY SIRONA Inc will post 2.08 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 12th. Shareholders of record on Friday, September 28th will be given a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date is Thursday, September 27th. DENTSPLY SIRONA’s dividend payout ratio is presently 13.16%.

Several equities analysts have weighed in on XRAY shares. ValuEngine upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a report on Monday, August 13th. Jefferies Financial Group decreased their price objective on shares of DENTSPLY SIRONA from $58.00 to $46.00 and set a “buy” rating on the stock in a report on Wednesday, August 8th. Morgan Stanley cut their target price on shares of DENTSPLY SIRONA from $65.00 to $54.00 and set an “overweight” rating on the stock in a research note on Thursday, June 14th. TheStreet downgraded shares of DENTSPLY SIRONA from a “c-” rating to a “d+” rating in a research note on Tuesday, August 14th. Finally, Stifel Nicolaus cut their target price on shares of DENTSPLY SIRONA from $57.00 to $46.00 and set a “buy” rating on the stock in a research note on Wednesday, August 8th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $52.18.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Article: Stock Symbols, CUSIP and Other Stock Identifiers

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.